首页> 美国卫生研究院文献>other >Oral Fluid and Plasma 34-Methylenedioxymethamphetamine (MDMA) and Metabolite Correlation after Controlled Oral MDMA Administration
【2h】

Oral Fluid and Plasma 34-Methylenedioxymethamphetamine (MDMA) and Metabolite Correlation after Controlled Oral MDMA Administration

机译:在受控口服MDMA施用后口服液和血浆34-甲基二氧基甲嘧啶(MDMA)和代谢物相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral fluid (OF) offers a non-invasive sample collection for drug testing. However, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) in OF has not been adequately characterized in comparison to plasma. We administered oral low (1.0 mg/kg) and high (1.6 mg/kg) dose MDMA to 26 participants and collected simultaneous OF and plasma specimens for up to 143 h after dosing. We compared OF/plasma (OF/P) ratios, time of initial detection (tfirst), maximal concentrations (Cmax), time of peak concentrations (tmax), time of last detection (tlast), clearance, and 3,4-methylenedioxyamphetamine (MDA) to MDMA ratios over time.For OF MDMA and MDA, Cmax was higher, tlast was later, and clearance was slower compared to plasma. For OF MDA only, tfirst was later compared to plasma. Median (range) OF/P ratios were 5.6 (0.1-52.3) for MDMA and 3.7 (0.7-24.3) for MDA. OF and plasma concentrations were weakly but significantly correlated (MDMA R2= 0.438, MDA R2= 0.197, p<0.0001). Median OF/P ratios were significantly higher following high dose: MDMA low 5.2 (0.1-40.4) and high 6.0 (0.4-52.3) (p<0.05); MDA low 3.3 (0.7-17.1) and high 4.1 (0.9-24.3) (p<0.001). There was large inter-subject variation in OF/P ratios. MDA/MDMA ratios in plasma were higher than those in OF (p<0.001), and MDA/MDMA ratios significantly increased over time in OF and plasma.MDMA and MDA concentrations were higher in OF than in plasma. OF and plasma concentrations were correlated, but large inter-subject variability precludes estimation of plasma concentrations from OF.
机译:口服液(OF)提供了用于药物测试的非侵入性样品采集。但是,与血浆相比,OF中的3,4-亚甲基二氧基甲基苯丙胺(摇头丸,摇头丸)尚未得到充分表征。我们向26名参与者施用了口服低剂量(1.0 mg / kg)和高剂量(1.6 mg / kg)的MDMA,并在给药后长达143小时同时收集OF和血浆标本。我们比较了OF /血浆(OF / P)比率,初始检测时间(tfirst),最大浓度(Cmax),峰浓度时间(tmax),最后检测时间(tlast),清除率和3,4-亚甲二氧基苯丙胺(MDA)与MDMA的比率随时间的变化。与血浆相比,对于MDMA和MDA,Cmax更高,延滞时间更晚,清除速度更慢。仅对于OF MDA,随后将tfirst与血浆进行比较。 MDMA的OF / P中位数(范围)比率为5.6(0.1-52.3),MDA为3.7(0.7-24.3)。 OF与血浆浓度之间存在弱相关性,但相关性很强(MDMA R 2 = 0.438,MDA R 2 = 0.197,p <0.0001)。高剂量后,OF / P中位数比率显着更高:MDMA低5.2(0.1-40.4)和高6.0(0.4-52.3)(p <0.05); MDA低3.3(0.7-17.1)和高4.1(0.9-24.3)(p <0.001)。 OF / P比率的受试者间差异很大。血浆中的MDA / MDMA比值高于OF(p <0.001),并且OF和血浆中的MDA / MDMA比值随时间显着增加.OF中的MDMA和MDA浓度高于血浆。 OF和血浆浓度是相关的,但是受试者之间的较大差异使得无法从OF估算血浆浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号